Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriatic Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04957550
What this trial is testing

To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Jiangsu HengRui Medicine Co., Ltd. 418
Post-approval studies (Phase 4)Study completedNCT02814175
What this trial is testing

Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

Who this might be right for
Psoriatic Arthritis
AbbVie 246
Early research (Phase 1)Study completedNCT00051662
What this trial is testing

Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
XOMA (US) LLC 45
Testing effectiveness (Phase 2)Study completedNCT02319759
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Janssen Research & Development, LLC 149
Testing effectiveness (Phase 2)Looking for participantsNCT07315061
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis

Who this might be right for
PsA (Psoriatic Arthritis)
InventisBio Co., Ltd 222
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Large-scale testing (Phase 3)Study completedNCT03370133
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 567
Early research (Phase 1)Study completedNCT03254784
What this trial is testing

Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation

Who this might be right for
Systemic Lupus ErythematosusArthritic PsoriasisPsoriasis+1 more
Bristol-Myers Squibb 49
Testing effectiveness (Phase 2)Study completedNCT05055934
What this trial is testing

Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 112
Testing effectiveness (Phase 2)Study completedNCT02986373
What this trial is testing

Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)

Who this might be right for
Psoriatic Arthritis
AbbVie 145
Early research (Phase 1)Study completedNCT03469336
What this trial is testing

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 18
Testing effectiveness (Phase 2)Ended earlyNCT02429895
What this trial is testing

A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197

Who this might be right for
Psoriatic Arthritis
AbbVie 168
Large-scale testing (Phase 3)Study completedNCT03895203
What this trial is testing

Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Biopharma SRL 852
Early research (Phase 1)Study completedNCT01199809
What this trial is testing

RO5310074 in Patients With Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Hoffmann-La Roche 19